- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 7 Reference Ions Near m/z 815.5648
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000055551 Reliable | 815.5663 | 815.5661 ~ 815.5667 MzDiff: 2.8 ppm |
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) (BioDeep_00000215565) Formula: C43H79N2O10P (814.5472) |
9.86 (89%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000046392 Reliable | 815.5744 | 815.5744 ~ 815.5744 MzDiff: none |
PA(22:0/20:3(8Z,11Z,14Z)-2OH(5,6)) (BioDeep_00000190588) Formula: C45H83O10P (814.5724) |
4.92 (100%) | Mus musculus [UBERON:0002107] liver |
MSI_000056804 Unreliable | 815.5647 | 815.5646 ~ 815.5648 MzDiff: 0.9 ppm |
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) (BioDeep_00000215565) Formula: C43H79N2O10P (814.5472) |
4.81 (60%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000065358 Unreliable | 815.5646 | 815.5642 ~ 815.5649 MzDiff: 2.9 ppm |
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) (BioDeep_00000215565) Formula: C43H79N2O10P (814.5472) |
3.57 (100%) | Homo sapiens [UBERON:0001155] colon |
MSI_000047851 Unreliable | 815.5549 | 815.5549 ~ 815.5549 MzDiff: none |
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) (BioDeep_00000215565) Formula: C43H79N2O10P (814.5472) |
2.05 (100%) | Homo sapiens [UBERON:0013067] colorectal mucosa |
MSI_000029241 Unreliable | 815.5578 | 815.5578 ~ 815.5578 MzDiff: none |
PS(18:1(11Z)/20:1(11Z)) (BioDeep_00000104752) Formula: C44H82NO10P (815.5676) |
1.52 (100%) | Macropus giganteus [UBERON:0002336] corpus callosum |
MSI_000056285 Unavailable | 815.5671 | 815.5671 ~ 815.5671 MzDiff: none |
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) (BioDeep_00000215565) Formula: C43H79N2O10P (814.5472) |
-0.59 (100%) | Homo sapiens [UBERON:0007779] transudate |
Found 25 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 17.4) |
Mus musculus (Lung) |
image3Resolution: 40μm, 146x190
Fig. 4 MALDI-MSI data of mouse lung tissue after administration with D9-choline and U13C-DPPC–containing Poractant alfa surfactant (labels administered 12 h prior to tissue collection). Ion images of (A) m/z 796.6856 ([U13C-DPPC+Na]+), (B) m/z 756.5154 [PC32:0+Na]+), and (C) m/z 765.6079 ([D9-PC32:0+Na]+). D: Overlay image of [U13C-PC32:0+Na]+ (red) and [D9-PC32:0+Na]+ (green). Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
PS(18:1(11Z)/20:1(11Z)) Formula: C44H82NO10P (815.5676) Adducts: [M]+ (Ppm: 11.3) |
Macropus giganteus (Brain) |
170321_kangaroobrain-dan3-pos_maxof50.0_med1Resolution: 50μm, 81x50
Sample information
Organism: Macropus giganteus (kangaroo)
Organism part: Brain
Condition: Wildtype
Sample growth conditions: Wild |
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 15) |
Homo sapiens (esophagus) |
LNTO22_1_3Resolution: 75μm, 121x68
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 9.7) |
Homo sapiens (esophagus) |
LNTO22_1_4Resolution: 17μm, 82x80
|
|
PE(20:2(11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C47H78NO8P (815.5465) Adducts: [M-H2O+NH4]+ (Ppm: 4.5) |
Homo sapiens (esophagus) |
LNTO22_1_9Resolution: 75μm, 89x74
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 7.5) |
Mus musculus (Liver) |
Salmonella_final_pos_recalResolution: 17μm, 691x430
A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium.
[dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671. |
|
PA(22:0/20:3(8Z,11Z,14Z)-2OH(5,6)) Formula: C45H83O10P (814.5724) Adducts: [M+H]+ (Ppm: 6.4) |
Mus musculus (Liver) |
Salmonella_final_pos_recalResolution: 17μm, 691x430
A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium.
[dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671. |
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 12.4) |
Homo sapiens (esophagus) |
LNTO29_16_3Resolution: 17μm, 108x107
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 14.5) |
Homo sapiens (esophagus) |
LNTO26_7_1Resolution: 17μm, 75x74
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 15.5) |
Homo sapiens (esophagus) |
LNTO26_7_2Resolution: 17μm, 135x101
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 14.2) |
Homo sapiens (esophagus) |
LNTO26_7_3Resolution: 75μm, 82x88
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 14.2) |
Homo sapiens (esophagus) |
TO29TResolution: 75μm, 56x48
|
|
PE(20:2(11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C47H78NO8P (815.5465) Adducts: [M-H2O+NH4]+ (Ppm: 6.1) |
Homo sapiens (esophagus) |
LNTO30_17_2Resolution: 75μm, 82x54
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 15.6) |
Homo sapiens (esophagus) |
LNTO22_1_5Resolution: 75μm, 135x94
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 14.1) |
Homo sapiens (esophagus) |
LNTO22_1_7Resolution: 75μm, 69x54
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 14.2) |
Homo sapiens (esophagus) |
LNTO22_1_8Resolution: 75μm, 69x61
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 14.4) |
Homo sapiens (esophagus) |
LNTO22_2_1Resolution: 75μm, 89x88
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 14.7) |
Homo sapiens (esophagus) |
LNTO22_2_2Resolution: 75μm, 135x94
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 14.4) |
Homo sapiens (esophagus) |
LNTO26_16_1Resolution: 75μm, 95x88
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 12.5) |
Homo sapiens (esophagus) |
LNTO29_18_2Resolution: 75μm, 62x68
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 12.7) |
Homo sapiens (esophagus) |
LNTO30_7_1Resolution: 75μm, 69x68
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 12.5) |
Homo sapiens (colorectal adenocarcinoma) |
240TopL, 210TopR, 230BottomL, 220BottomR-centroidResolution: 50μm, 142x141
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 12.8) |
Homo sapiens (colorectal adenocarcinoma) |
200TopL, 170TopR, 190BottomL, 180BottomR-centroidResolution: 50μm, 132x126
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 11.9) |
Homo sapiens (colorectal adenocarcinoma) |
160TopL,130TopR,150BottomL,140BottomR-centroidResolution: 50μm, 142x136
|
|
SM(d18:2(4E,14Z)/6 keto-PGF1alpha) Formula: C43H79N2O10P (814.5472) Adducts: [M+H]+ (Ppm: 13) |
Homo sapiens (colorectal adenocarcinoma) |
120TopL, 90TopR, 110BottomL, 100BottomR-centroidResolution: 50μm, 132x136
|
|